Cambridge Biotherapies Set to Transform Lives with New Affordable Depression Treatment
Cambridge Biotherapies™, a leader in advanced mental health treatments, proudly announces the introduction of Spravato™ (esketamine) nasal spray therapy at...
Cambridge Biotherapies™, a leader in advanced mental health treatments, proudly announces the introduction of Spravato™ (esketamine) nasal spray therapy at...
Insurance-based mental healthcare provider Heading, specializing in treating patients with chronic depression and trauma through Ketamine and Spravato® will begin accepting...